Corvair vs EchoGo Amyloidosis
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Corvair focuses on AI-powered analysis of resting diagnostic ECGs to provide 35 general cardiac determinations, assisting healthcare professionals with broad ECG interpretation. EchoGo Amyloidosis, conversely, is an AI-powered screening tool that analyzes echocardiogram video clips specifically for the early detection of cardiac amyloidosis. While both are FDA-cleared cardiology AI tools, they utilize different diagnostic modalities and target distinct clinical applications.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Corvair by AliveCor analyzes 10-second resting diagnostic ECGs to assist in interpretation. Ultromics' EchoGo Amyloidosis analyzes echocardiogram video clips to identify suspected cardiac amyloidosis.
Corvair provides 35 cardiac determinations (14 rhythm, 21 morphology) to assist in interpreting general resting diagnostic ECGs. EchoGo Amyloidosis is specifically designed as a screening tool to aid in the early detection of cardiac amyloidosis.
Corvair provides automated interpretations with 35 cardiac determinations that are reviewable by a healthcare professional. EchoGo Amyloidosis provides a diagnostic output of 'suggestive' or 'not suggestive' of cardiac amyloidosis.
Corvair requires standard diagnostic-bandwidth ECG recordings using only 4 ECG leads for its analysis. EchoGo Amyloidosis analyzes echocardiogram video clips as its input.
For EchoGo Amyloidosis, there are specific NTAP and HCPCS codes with stated Medicare and select commercial insurer coverage details. Pricing for Corvair requires contacting the vendor directly.
EchoGo Amyloidosis reports high diagnostic accuracy with 85% sensitivity and 93% specificity for identifying suspected cardiac amyloidosis. The provided information for Corvair does not include specific diagnostic accuracy metrics.
Corvair is a cloud-based Software as a Medical Device (SaMD) with automated interpretations reviewable by HCPs. EchoGo Amyloidosis is designed for seamless integration with existing clinical workflows and IT infrastructure, including PACS, DICOM, and HL7.
More Comparisons
Backers
Who funded each tool's parent company.